Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
S100A2
100%
Conditionally Replicating Adenovirus
100%
Epidermal Growth Factor Receptor
55%
Antitumor Activity
33%
Promoter Activity
22%
Adenovirus
22%
Cetuximab
22%
Epidermal Growth Factor Receptor Signaling
22%
Combined Treatment
11%
Tumor Suppressor
11%
Tumor
11%
Anticancer Drugs
11%
Oncogenesis
11%
Tumor Cells
11%
Concentration-dependent
11%
Immunohistochemical Analysis
11%
Cisplatin
11%
In Vitro Activity
11%
Potent Inhibitor
11%
Viable Cells
11%
Receptor Targets
11%
Xenograft Animal Model
11%
Tumor Xenograft
11%
Nuclear Targeting
11%
Calcium-binding Proteins
11%
Receptor Phosphorylation
11%
Signal Inhibition
11%
S100 Family
11%
Tumor Section
11%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Promoter Region
100%
Epidermal Growth Factor Receptor
100%
Conditionally Replicating Adenovirus
100%
Antineoplastic Activity
42%
Neoplasm
28%
Adenoviridae
28%
Cetuximab
28%
Malignant Neoplasm
14%
Signal Transduction
14%
In Vitro
14%
Tumor Cell
14%
Cisplatin
14%
Anticarcinogen
14%
Carcinogenesis
14%
Tumor Xenograft
14%
Calcium-Binding Protein
14%
Tumor Suppressor Protein
14%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Epidermal Growth Factor Receptor
100%
Non Small Cell Lung Cancer
100%
Conditionally Replicating Adenovirus
100%
Adenoviridae
28%
Cetuximab
28%
Anticarcinogen
14%
Malignant Neoplasm
14%
Carcinogenesis
14%
Cisplatin
14%
Calcium Binding Protein
14%
Tumor Suppressor Protein
14%
Biochemistry, Genetics and Molecular Biology
Promoter Region
100%
Adenoviridae
100%
S100A2
100%
Epidermal Growth Factor Receptor
77%
Antineoplastic Activity
33%
Cetuximab
22%
Carcinogenesis
11%
Tumor Suppressor Protein
11%
Signal Transduction
11%
Animal Model
11%
Cisplatin
11%
Anticancer
11%
Calcium-Binding Protein
11%